Search

Author/Creator Pendyala, Srikanth

1. Revefenacin, a once-daily, lung-selective, long-acting muscarinic antagonist for nebulized therapy: Safety and tolerability results of a 52-week phase 3 trial in moderate to very severe chronic obstructive pulmonary disease. (July 2019)

Authors:
Donohue, James F.; Kerwin, Edward; Sethi, Sanjay; Haumann, Brett; Pendyala, Srikanth; Dean, Lorna; Barnes, Chris N.; Moran, Edmund J.; Crater, Glenn
Journal:
Respiratory medicine
Issue:
Volume 153(2019)
Page Start:
38
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Cardiovascular safety of revefenacin, a once-daily, lung-selective, long-acting muscarinic antagonist for nebulized therapy of chronic obstructive pulmonary disease: Evaluation in phase 3 clinical trials. (August 2019)

Authors:
Donohue, James F.; Feldman, Gregory; Sethi, Sanjay; Barnes, Chris N.; Pendyala, Srikanth; Bourdet, David; Crater, Glenn
Journal:
Pulmonary pharmacology & therapeutics
Issue:
Volume 57(2019)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Targeting sphingosine kinase 1 attenuates bleomycin‐induced pulmonary fibrosis. Issue 4 (11th January 2013)

Authors:
Huang, Long Shuang; Berdyshev, Evgeny; Mathew, Biji; Fu, Panfeng; Gorshkova, Irina A.; He, Donghong; Ma, Wenli; Noth, Imre; Ma, Shwu‐Fan; Pendyala, Srikanth; Reddy, Sekhar P.; Zhou, Tong; Zhang, Wei; Garzon, Steven A.; Garcia, Joe G. N.; Natarajan, Viswanathan
Journal:
FASEB journal
Issue:
Volume 27:Issue 4(2013)
Page Start:
1749
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Revefenacin, a Long‐Acting Muscarinic Antagonist, Does Not Prolong QT Interval in Healthy Subjects: Results of a Placebo‐ and Positive‐Controlled Thorough QT Study. Issue 1 (29th August 2019)

Authors:
Borin, Marie T.; Barnes, Chris N.; Darpo, Borje; Pendyala, Srikanth; Xue, Hongqi; Bourdet, David L.
Journal:
Clinical pharmacology in drug development
Issue:
Volume 9:Issue 1(2020)
Page Start:
130
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗